| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 骨疏康(元) | - | - | - | - | 96,017,718.67 |
| 荷丹片(元) | - | - | - | - | 57,760,960.14 |
| 脑血疏口服液(元) | - | - | - | - | 53,797,854.10 |
| 心可舒片(元) | - | - | - | - | 143,721,605.69 |
| 肌肉骨骼系统药物(元) | 82,435,570.57 | 182,504,204.98 | 99,775,912.64 | 186,279,827.16 | - |
| 抗病毒类呼吸系统药物(元) | 10,395,610.30 | 26,092,335.46 | 12,621,484.38 | 22,026,227.87 | - |
| 生殖泌尿系统药物(元) | 2,902,416.15 | 6,905,207.64 | 3,444,254.33 | 7,643,824.70 | - |
| 心脑血管系统药物(元) | 282,032,775.95 | 568,806,472.55 | 294,230,400.03 | 506,479,752.87 | - |
| 其他(元) | 15,583,139.80 | 32,644,204.21 | 15,286,434.40 | 41,363,761.49 | 43,855,537.61 |
| 营业成本(元) | |||||
| 骨疏康(元) | - | - | - | - | 43,898,552.76 |
| 荷丹片(元) | - | - | - | - | 10,347,119.96 |
| 脑血疏口服液(元) | - | - | - | - | 11,337,120.99 |
| 心可舒片(元) | - | - | - | - | 26,342,599.09 |
| 肌肉骨骼系统药物(元) | 33,862,297.93 | 77,166,383.05 | 42,685,224.64 | 82,392,328.65 | - |
| 抗病毒类呼吸系统药物(元) | - | 13,581,391.16 | - | 11,322,120.97 | - |
| 生殖泌尿系统药物(元) | - | 4,831,559.47 | - | 6,575,498.31 | - |
| 心脑血管系统药物(元) | 42,130,510.27 | 94,278,153.69 | 51,411,369.47 | 97,388,496.39 | - |
| 其他(元) | - | 11,257,161.00 | - | 11,842,847.05 | 17,866,598.58 |
| 毛利(元) | |||||
| 骨疏康(元) | - | - | - | - | 52,119,165.91 |
| 荷丹片(元) | - | - | - | - | 47,413,840.18 |
| 脑血疏口服液(元) | - | - | - | - | 42,460,733.11 |
| 心可舒片(元) | - | - | - | - | 117,379,006.60 |
| 肌肉骨骼系统药物(元) | 48,573,272.64 | 105,337,821.93 | 57,090,688.00 | 103,887,498.51 | - |
| 抗病毒类呼吸系统药物(元) | - | 12,510,944.30 | - | 10,704,106.90 | - |
| 生殖泌尿系统药物(元) | - | 2,073,648.17 | - | 1,068,326.39 | - |
| 心脑血管系统药物(元) | 239,902,265.68 | 474,528,318.86 | 242,819,030.56 | 409,091,256.48 | - |
| 其他(元) | - | 21,387,043.21 | - | 29,520,914.44 | 25,988,939.03 |
| 毛利率(%) | |||||
| 骨疏康(%) | - | - | - | - | 54.28 |
| 荷丹片(%) | - | - | - | - | 82.09 |
| 脑血疏口服液(%) | - | - | - | - | 78.93 |
| 心可舒片(%) | - | - | - | - | 81.67 |
| 肌肉骨骼系统药物(%) | 58.92 | 57.72 | 57.22 | 55.77 | - |
| 抗病毒类呼吸系统药物(%) | - | 47.95 | - | 48.60 | - |
| 生殖泌尿系统药物(%) | - | 30.03 | - | 13.98 | - |
| 心脑血管系统药物(%) | 85.06 | 83.43 | 82.53 | 80.77 | - |
| 其他(%) | - | 65.52 | - | 71.37 | 59.26 |
| 收入构成(%) | |||||
| 骨疏康(%) | - | - | - | - | 24.30 |
| 荷丹片(%) | - | - | - | - | 14.62 |
| 脑血疏口服液(%) | - | - | - | - | 13.61 |
| 心可舒片(%) | - | - | - | - | 36.37 |
| 肌肉骨骼系统药物(%) | 20.96 | 22.34 | 23.46 | 24.39 | - |
| 抗病毒类呼吸系统药物(%) | 2.64 | 3.19 | 2.97 | 2.88 | - |
| 生殖泌尿系统药物(%) | 0.74 | 0.85 | 0.81 | 1.00 | - |
| 心脑血管系统药物(%) | 71.70 | 69.63 | 69.17 | 66.31 | - |
| 其他(%) | 3.96 | 4.00 | 3.59 | 5.42 | 11.10 |
| 毛利构成(%) | |||||
| 骨疏康(%) | - | - | - | - | 18.26 |
| 荷丹片(%) | - | - | - | - | 16.62 |
| 脑血疏口服液(%) | - | - | - | - | 14.88 |
| 心可舒片(%) | - | - | - | - | 41.13 |
| 肌肉骨骼系统药物(%) | 16.84 | 17.10 | 19.04 | 18.74 | - |
| 抗病毒类呼吸系统药物(%) | 0.00 | 2.03 | 0.00 | 1.93 | - |
| 生殖泌尿系统药物(%) | 0.00 | 0.34 | 0.00 | 0.19 | - |
| 心脑血管系统药物(%) | 83.16 | 77.05 | 80.96 | 73.81 | - |
| 其他(%) | 0.00 | 3.47 | 0.00 | 5.33 | 9.11 |